Dr. Carlos González is currently Professor of Andrés Bello University and  Director of the School of Veterinary Medicine of the Andrés Bello University. He obtained a bachelor’s degree in Veterinary Sciences and a professional degree in Veterinary Medicine from the University of Chile and later completed a specialization program in Histopathology and Cytopathology in the Department of Experimental Medicine of the Faculty of Medicine of the University of Chile. He was awarded a scholarship by the British Council and Andes Foundation, to enroll at the Royal (Dick) School of Veterinary Medicine of the University of Edinburgh, Scotland, United Kingdom. There, he obtained a Master of Philosophy (MPhil) degree with a mention in immunopathology and later obtained the Doctor of Philosophy (PhD) degree with mention in immunopathology. After he returned and until 2007, he worked in the Department of Animal Pathology at the University of Chile, actively participating in undergraduate and postgraduate teaching, research and diagnostic service, in the area of ​​Animal Pathology. At the same time, he has actively contributed to the development of diagnostic pathology in support of clinical activity, founding Citovet, the first private laboratory specialized in veterinary diagnostic pathology.  He also collaborates with state and private organizations in the area of ​​Forensic Veterinary Pathology. He is a member of the postgraduate committee of the veterinary sciences area of ​​the CNA (National Accreditation Commission) and currently president of AFEVET (Association of Accredited Veterinary Medicine Faculties and Schools of Chile).

DESCRIPTION OF RESEARCH INTEREST

He began working on the development of hybridomas and monoclonal antibodies for the phenotyping and detection of macrophages, to later focus on the area of ​​immunohistochemistry and computationally assisted morphometry. His area of ​​research has focused mainly on Comparative Pathology studies. He has been mainly dedicated to the study of immunopathological aspects of inflammatory diseases and cancer, using experimental and clinical models. He has participated in several FONDECYT research projects, as principal investigator, co-investigator and collaborator. He also participates in other extramural and internal UNAB projects.